Beximco to provide COVID-19 vaccine in Bangladesh
Image collected
Beximco Pharmaceuticals is to collaborate with the Serum Institute of India to become the exclusive supplier of AstraZeneca’s COVID-19 vaccine in Bangladesh, should the product be approved.
Beximco will make a financial contribution to advance the development of the vaccine, which is adjusted in line with the vaccine price.
The company may also secure additional quantities of the vaccine to be distributed to the private market in Bangladesh.
The investment amount will rely upon regulatory approvals, production capacity and earlier commitments abroad.
Source: https://www.thepharmaletter.com
Tags :
Previous Story
- PPE exports open new avenue for Bangladesh
- Bangladesh pharma claims to be first to launch...
- Four-fold jump in LPG consumption but industry faces...
- Most pharma cos report higher earnings in Q1...
- Fastest growing Asian economy, Bangladesh explores equitable sustainable...
- Most pharmaceutical companies report higher EPS
- BAPI congratulates PM’s new adviser Salman F Rahman
- Dhaka stocks fall amid topsy-turvy trading